Skip to content

Fiber Optic Biosensors for Triple-Negative Breast Cancer Cells Detection

Sep 2026 · Oncology, Nuclear Medicine and Transplantology · 0 citations

TL;DR

The developed fiber-optic biosensors show potential for integration into liquid biopsy platforms for label-free detection of circulating tumor cells in biological fluids, providing a rapid and minimally invasive approach for cancer detection and monitoring.

Abstract

Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype lacking effective targeted therapies, highlighting the need for sensitive and selective cancer cell detection. Optical fiber biosensors offer high sensitivity, compact size, and label-free operation for cancer cell detection. This study developed a quasi-random extrinsic interferometer-based fiber-optic biosensor for label-free TNBC cell detection using two complementary recognition strategies: gold–anti-CD44 antibody functionalization and polydopamine (PDA)-based molecularly imprinted polymer (MIP) recognition. The performance of these functionalized sensors was evaluated for selective recognition of TNBC cells, demonstrating their potential as a sensitive and label-free detection platform. Materials and Methods: A quasi-random extrinsic interferometer-based fiber-optic sensor was fabricated and coated with polydimethylsiloxane (PDMS), a biocompatible polymer widely used in biomedical applications. For antibody-based recognition, a gold-coated surface was functionalized with anti-CD44 antibodies to target HCC1806 breast cancer cells, with HEK293 cells used as a control. For synthetic recognition, dopamine was polymerized on the sensor surface to form a polydopamine (PDA)-based molecularly imprinted polymer (MIP) designed to recognize HCC1806 and MDA-MB-231 cells. Optical responses at different cell concentrations were recorded using a fiber-optic interrogator, and sensor performance and cell attachment were evaluated by calibration analysis and scanning electron microscopy. Results and Conclusions: The developed fiber-optic biosensors show potential for integration into liquid biopsy platforms for label-free detection of circulating tumor cells in biological fluids, providing a rapid and minimally invasive approach for cancer detection and monitoring.

View source

Similar papers

Open access Sep 2026

An Optical Biosensor for Label-Free Detection of Soluble Biomarker: Toward Minimally Invasive Breast Cancer Monitoring

The development of a graphene oxide-coated fiber-optic biosensor based on a semi-distributed interferometric sensing platform for the highly sensitive detection of solCD44, a cell adhesion glycoprotein whose soluble form is elevated in several cancers including breast cancer, is reported.

K. Seitkamal, A. Bekmurzayeva, A. Aubakirova et al. · 0 citations
Oct 2026

Nano-colorimetric sensing coupled with a smartphone platform for highly sensitive detection of MDA-MB-231 cells.

Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer (BC), and the precise detection of MDA-MB-231 cells is important for the early diagnosis, disease monitoring, and evaluation of treatment efficacy in TNBC. However, traditional detection methods have disadvantages such as compl...

Jiao-Yan Qiu, Ying-Qi Chen, Yuan-Fei Wang et al. · 0 citations
Sep 2026

Molecularly Imprinted Polymer Biofunctionalized Optical Fiber-Tip Quasi-Random Extrinsic Interferometer for Selective Triple-Negative Breast Cancer Cells Detection

Introduction: The study of triple-negative breast cancer cells detection is one of the important research fields in modern biomedical engineering, due to its aggressive behavior and limited targeting options. One of the promising methods for cancer cell detection is using Molecularly Imprinted Polymers (MIPs) with poly...

Bakdaulet Yendibay, Akmaral Suleimenova, Aigerim Omirzakova et al. · 0 citations
Open access Aug 2026

Label-Free Refractive-Index-Based Detection of Breast, Leukemia, and Prostate Cancer Cells Using a Tetra-Core PCF SPR Biosensor

In this research, a high-performance plasmonic refractive index (RI) biosensor based on an external metal deposition (EMD) technique and photonic crystal fiber (PCF) platform for potential cancer detection is presented, investigated, and linked with real-time cancer cells. Variations in the RI of biological fluids are...

A. K. Shakya, M. Grigalavičius · 3 citations
Review Sep 2026

Translational optical and electrochemical biosensing strategies for liquid biopsy in triple-negative breast Cancer: advances, challenges, and clinical implementation.

This review systematically correlates TNBC biomarkers with optimal sensing technologies, emphasizing how biomolecular properties affect sensor selection and performance and emphasizes future integration of biosensors with CTC-derived organoids, microfluidics, AI, and multiplexed detection to enable portable, clinically...

Karim G. Mohammed, M. Abdelgawad, Mohamed S. Attia · 0 citations
Aug 2026

Label- and- enzyme free electrochemical DNA biosensor for ultrasensitive detection of breast cancer prognostic marker ESR1.

Breast cancer is a complex heterogeneous disease that continues to impose a substantial global burden on women's health. Analysis of ESR1 gene expression using non-invasive liquid biopsy has significant prognostic value, serving as an indicator of poor prognosis and overall survival (OS) in patients with ER+/HER-2- (Es...

A. Khalil, Waleed O Arafat, A. F. El-Bab et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.